Skip to main content
. 2021 May 26;321(1):C158–C175. doi: 10.1152/ajpcell.00118.2021

Figure 10.

Figure 10.

Effect of forskolin on human AZG K+ currents. A: inhibition of TREK-1. K+ currents were recorded in response to voltage steps to +20 mV applied at 30 s intervals from a holding potential of −80 mV. TREK-1 amplitudes are plotted against time. Numbers on plot correspond to those on traces before and after 5 µM forskolin. B: inhibition of TREK-1 and KIR by forskolin. K+ currents were recorded in response to voltage steps to test potentials from +40 to −120 mV applied at 30 s intervals from a holding potential of −60 mV. Traces show IVs in control saline and in 5 µM forskolin. C: inhibited K+ currents and I-Vs. Difference current traces obtained by digital subtraction of K+ currents in forskolin from control currents. Current amplitudes from B are plotted against test potential. Number of independent experiments: n = 6 (A); n = 2 (B and C).